Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
Journal of Pharmaceutical Sciences
|
August 1, 1983
Hydrazine levels in formulations of hydralazine, isoniazid, and phenelzine over a 2-year period
E G Lovering, F Matsui, N M Curran, et al.
Journal of Pharmaceutical Sciences
|
May 1, 1979
Stability-indicating high-performance liquid chromatographic determination of chlorpropamide, tolbutamide, and their respective sulfonamide degradates
D L Robertson, A G Butterfield, H Kolasinski, et al.
Journal of Lipid Mediators
|
March 1, 1993
Drug inhibition and cellular regulation of prostaglandin G/H synthase isoenzyme 2
D L Simmons, W Xie, G Evett, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1991
Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
W L Xie, J G Chipman, D L Robertson, et al.
Virology
|
February 17, 1997
A full-length and replication-competent proviral clone of SIVAGM from tantalus monkeys
M A Soares, D L Robertson, H Hui, et al.
Journal of Virology
|
April 1, 1976
Relationships between intracisternal type A and extracellular oncornavirus-like particles produced in murine MOPC-460 myeloma cells
D L Robertson, P Yau, D C Dobbertin, et al.
The Journal of Infectious Diseases
|
June 1, 1992
Detection of spores of Bacillus anthracis using the polymerase chain reaction
M Carl, R Hawkins, N Coulson, et al.
Molecular Biology and Evolution
|
December 30, 2006
One billion years of bZIP transcription factor evolution: conservation and change in dimerization and DNA-binding site specificity
G D Amoutzias, A S Veron, J Weiner, et al.
Virology
|
February 13, 2001
Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france
F Damond, C Apetrei, D L Robertson, et al.
Antiviral Chemistry & Chemotherapy
|
August 3, 2021
V3-Loop genotypes do not predict maraviroc susceptibility of CCR5-tropic virus or clinical response through week 48 in HIV-1-infected, treatment-experienced persons receiving optimized background regimens
M E Lewis, P Simpson, J Mori, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
Journal of Pharmaceutical Sciences
|
August 1, 1983
Hydrazine levels in formulations of hydralazine, isoniazid, and phenelzine over a 2-year period
E G Lovering, F Matsui, N M Curran, et al.
Journal of Pharmaceutical Sciences
|
May 1, 1979
Stability-indicating high-performance liquid chromatographic determination of chlorpropamide, tolbutamide, and their respective sulfonamide degradates
D L Robertson, A G Butterfield, H Kolasinski, et al.
Journal of Lipid Mediators
|
March 1, 1993
Drug inhibition and cellular regulation of prostaglandin G/H synthase isoenzyme 2
D L Simmons, W Xie, G Evett, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1991
Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
W L Xie, J G Chipman, D L Robertson, et al.
Virology
|
February 17, 1997
A full-length and replication-competent proviral clone of SIVAGM from tantalus monkeys
M A Soares, D L Robertson, H Hui, et al.
Journal of Virology
|
April 1, 1976
Relationships between intracisternal type A and extracellular oncornavirus-like particles produced in murine MOPC-460 myeloma cells
D L Robertson, P Yau, D C Dobbertin, et al.
The Journal of Infectious Diseases
|
June 1, 1992
Detection of spores of Bacillus anthracis using the polymerase chain reaction
M Carl, R Hawkins, N Coulson, et al.
Molecular Biology and Evolution
|
December 30, 2006
One billion years of bZIP transcription factor evolution: conservation and change in dimerization and DNA-binding site specificity
G D Amoutzias, A S Veron, J Weiner, et al.
Virology
|
February 13, 2001
Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france
F Damond, C Apetrei, D L Robertson, et al.
Antiviral Chemistry & Chemotherapy
|
August 3, 2021
V3-Loop genotypes do not predict maraviroc susceptibility of CCR5-tropic virus or clinical response through week 48 in HIV-1-infected, treatment-experienced persons receiving optimized background regimens
M E Lewis, P Simpson, J Mori, et al.
Page
of 7